Rezolute (RZLT) Share-based Compensation (2011 - 2026)
Rezolute (RZLT) posted Share-based Compensation of $4.4 million for Q1 2026, up 29.58% sequentially from $3.4 million in Q4 2025, and up 132.02% YoY from $1.9 million in Q1 2025.
Analysis
Rezolute (RZLT) Share-based Compensation (2011 - 2026) Analysis & Trends
Rezolute has reported Share-based Compensation for 16 years, with the latest figure at $4.4 million in Q1 2026.
- Quarterly Share-based Compensation rose 132.02% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 2.97% YoY) and the FY2025 annual result came in at $18.7 million, up 61.21% from the prior year.
- Share-based Compensation grew to $4.4 million in Q1 2026 per RZLT's latest filing, from $3.4 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $16.2 million in Q3 2025 and troughed at -$3.3 million in Q2 2023.
- A 5-year average of $2.8 million and a median of $1.9 million in 2023 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation plunged 3361.0% in 2023, then soared 1057.14% in 2025.
- Over 5 years, Share-based Compensation stood at $1.7 million in 2022, then rose by 6.12% to $1.8 million in 2023, then slipped by 21.34% to $1.4 million in 2024, then jumped by 136.06% to $3.4 million in 2025, then grew by 29.58% to $4.4 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $4.4 million, $3.4 million, and $16.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 120.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 277.20 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 137.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | 22.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 22.14 Mn |
| Dec 31, 2025 | 22.89 Mn |
| Sep 30, 2025 | 15.46 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 15.93 Mn |
| Dec 31, 2024 | 15.94 Mn |
| Sep 30, 2024 | 11.20 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 11.31 Mn |
| Dec 31, 2023 | 11.04 Mn |
| Sep 30, 2023 | 11.04 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 11.06 Mn |
| Dec 31, 2022 | 11.16 Mn |
| Sep 30, 2022 | 11.19 Mn |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 1.71 Mn |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 1.66 Mn |